These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. COVID-19: Can the symptomatic SARS-CoV-2 infection affect the homeostasis of the gut-brain-microbiota axis? Chaves Andrade M; Souza de Faria R; Avelino Mota Nobre S Med Hypotheses; 2020 Nov; 144():110206. PubMed ID: 33254513 [TBL] [Abstract][Full Text] [Related]
28. Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8 Lehmann M; Allers K; Heldt C; Meinhardt J; Schmidt F; Rodriguez-Sillke Y; Kunkel D; Schumann M; Böttcher C; Stahl-Hennig C; Elezkurtaj S; Bojarski C; Radbruch H; Corman VM; Schneider T; Loddenkemper C; Moos V; Weidinger C; Kühl AA; Siegmund B Mucosal Immunol; 2021 Nov; 14(6):1381-1392. PubMed ID: 34420043 [TBL] [Abstract][Full Text] [Related]
29. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment. Wang M; Zhang Y; Li C; Chang W; Zhang L Front Immunol; 2023; 14():1180336. PubMed ID: 37205106 [TBL] [Abstract][Full Text] [Related]
30. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients. Soltani S; Zakeri A; Zandi M; Kesheh MM; Tabibzadeh A; Dastranj M; Faramarzi S; Didehdar M; Hafezi H; Hosseini P; Farahani A Biomed Res Int; 2021; 2021():6670798. PubMed ID: 33681368 [TBL] [Abstract][Full Text] [Related]
31. Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota. Tieu V; Tibi S; Ling J Front Cell Infect Microbiol; 2023; 13():1167827. PubMed ID: 37457959 [TBL] [Abstract][Full Text] [Related]
32. The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection. Penninger JM; Grant MB; Sung JJY Gastroenterology; 2021 Jan; 160(1):39-46. PubMed ID: 33130103 [TBL] [Abstract][Full Text] [Related]
33. Intestinal Microbiota-A Promising Target for Antiviral Therapy? Yang M; Yang Y; He Q; Zhu P; Liu M; Xu J; Zhao M Front Immunol; 2021; 12():676232. PubMed ID: 34054866 [TBL] [Abstract][Full Text] [Related]
34. Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 Vignesh R; Swathirajan CR; Tun ZH; Rameshkumar MR; Solomon SS; Balakrishnan P Front Immunol; 2020; 11():607734. PubMed ID: 33569053 [No Abstract] [Full Text] [Related]
35. Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host. Lloréns-Rico V; Gregory AC; Van Weyenbergh J; Jansen S; Van Buyten T; Qian J; Braz M; Menezes SM; Van Mol P; Vanderbeke L; Dooms C; Gunst J; Hermans G; Meersseman P; ; Wauters E; Neyts J; Lambrechts D; Wauters J; Raes J Nat Commun; 2021 Oct; 12(1):6243. PubMed ID: 34716338 [TBL] [Abstract][Full Text] [Related]
36. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences. Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423 [TBL] [Abstract][Full Text] [Related]
37. Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19. Ren L; Wang Y; Zhong J; Li X; Xiao Y; Li J; Yang J; Fan G; Guo L; Shen Z; Kang L; Shi L; Li Q; Li J; Di L; Li H; Wang C; Wang Y; Wang X; Zou X; Rao J; Zhang L; Wang J; Huang Y; Cao B; Wang J; Li M Am J Respir Crit Care Med; 2021 Dec; 204(12):1379-1390. PubMed ID: 34534435 [No Abstract] [Full Text] [Related]
39. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases. Dumas A; Bernard L; Poquet Y; Lugo-Villarino G; Neyrolles O Cell Microbiol; 2018 Dec; 20(12):e12966. PubMed ID: 30329198 [TBL] [Abstract][Full Text] [Related]
40. Prevalence and Clinical Impact of Viral and Bacterial Coinfections in Hospitalized Children and Adolescents Aged under 18 Years with COVID-19 during the Omicron Wave in Russia. Yakovlev AS; Afanasev VV; Alekseenko SI; Belyaletdinova IK; Isankina LN; Gryaznova IA; Skalny AV; Kozlovskaya LI; Ishmukhametov AA; Karganova GG Viruses; 2024 Jul; 16(8):. PubMed ID: 39205154 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]